Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Tissue Procurement For Hematolymphoid Conditions
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 120 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
DISEASE CHARACTERISTICS: * Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following: * Acute myeloid leukemia * Acute lymphoblastic leukemia * Chronic myelogenous leukemia * Chronic lymphoid leukemia * Non-Hodgkin lymphoma * Hodgkin lymphoma * Myelodysplastic syndromes * Myeloproliferative disorders * Multiple myeloma * Waldenstrom macroglobulinemia * Aplastic anemia * Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage * Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified
Study sites (1)
NC
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill · Chapel Hill, NC 27599-7295Tissue Procurement Facility · Study contact · 919-966-2620More trials in Chapel Hill